Ye Liu, Director at EyePoint Pharmaceuticals, Inc. (EYPT), sold 1 shares at $6.00 ($6) on 2023-05-30, disclosed to the SEC on 2023-05-31.
Open-market sale of $6 EYPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |